Role of cardiac imaging in management of heart failure

키워드

참고문헌 (68)

1. Park Jin Joo, "Heart Failure Statistics in Korea, 2020: A Report from the Korean Society of Heart Failure", International Journal of Heart Failure, 3(4), pp.224~ (2021), 대한심부전학회[DOI]
2. Marwick TH, "Methods used for the assessment of LV systolic function : common currency or tower of Babel?", Heart, 99, pp.1078~1086 (2013)
3. McDonagh TA, "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure", Eur Heart J, 42, pp.3599~3726 (2021)
4. Pieske B, "How to diagnose heart failure with preserved ejection fraction : the HFA-PEFF diagnostic algorithm : a consensus recommendation from the Heart Failure Association(HFA)of the European Society of Cardiology(ESC)", Eur Heart J, 40, pp.3297~3317 (2019)
5. Mi-Na Kim, "Heart failure with preserved ejection fraction: insights from recent clinical researches", The Korean Journal of Internal Medicine, 35(3), pp.514~534 (2020), 대한내과학회[DOI]
6. Smiseth OA, "Multimodality imaging in patients with heart failure and preserved ejection fraction : an expert consensus document of the European Association of Cardiovascular Imaging", Eur Heart J Cardiovasc Imaging, 23, pp.e34~e61 (2022)
7. Kim MN, "Assessment of the left ventricular diastolic function and its association with the left atrial pressure in patients with atrial fibrillation", Int J Heart Fail, 2, pp.55~65 (2020)
8. Jørgensen Troels Højsgaard, "Transcatheter Implantation of Interatrial Shunt Devices to Lower Left Atrial Pressure in Heart Failure", International Journal of Heart Failure, 4(1), pp.12~ (2022), 대한심부전학회[DOI]
9. Kim Hee-Dong, "Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation", International Journal of Heart Failure, 4(1), pp.42~ (2022), 대한심부전학회[DOI]
10. Voigt JU, "Definitions for a common standard for 2D speckle tracking echocardiography : consensus document of the EACVI", ASE, J Am Soc Echocardiogr, pp.2015, 28[DOI]
11. Sarvari SI, "Early postoperative left ventricular function by echocardiographic strain is a predictor of 1-year mortality in heart transplant recipients", J Am Soc Echocardiogr, 25, pp.1007~1014 (2012)
12. Kim SA, "Assessment of left ventricular function by layer-specific strain and its relationship to structural remodelling in patients with hypertension", Can J Cardiol, 32, pp.211~216 (2016)
13. Zhang KW, "Strain improves risk prediction beyond ejection fraction in chronic systolic heart failure", J Am Heart Assoc, 3, pp.e000550~ (2014)
14. Yingchoncharoen T, "Normal ranges of left ventricular strain : a meta-analysis", J Am Soc Echocardiogr, 26, pp.185~191 (2013)
15. Santoro C, "2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients : a balance with feasibility", Eur Heart J Cardiovasc Imaging, 18, pp.930~936 (2017)
16. Kim MN, "Serial changes of layer-specific myocardial function according to chemotherapy regimen in patients with breast cancer", Eur Heart J Open, 2, pp.oeac008~ (2022)
17. Lyon AR, "2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)", Eur Heart J, 43, pp.4229~4361 (2022)
18. Thavendiranathan P, "Strain-guided management of potentially cardiotoxic cancer therapy", J Am Coll Cardiol, 77, pp.392~401 (2021)
19. Negishi T, "Cardioprotection using strain-guided management of potentially cardiotoxic cancer therapy : 3-year results of the SUCCOUR trial", JACC Cardiovasc Imaging, 16, pp.269~278 (2023)
20. Harjola VP, "Contemporary management of acute right ventricular failure : a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology", Eur J Heart Fail, 18, pp.226~241 (2016)
21. Rudski LG, "Guidelines for the echocardiographic assessment of the right heart in adults : a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography", J Am Soc Echocardiogr, 23, pp.685~713 (2010)
22. Wei K, "Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography : bolus or continuous infusion?", J Am Coll Cardiol, 32, pp.252~260 (1998)
23. Cardim N, "Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy : an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association", Eur Heart J Cardiovasc Imaging, 16, pp.280~ (2015)
24. Pellikka PA, "Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease : from the American Society of Echocardiography", J Am Soc Echocardiogr, 33, pp.1~41 (2020)
25. Vahanian A, "2021 ESC", EACTS Guidelines for the management of valvular heart disease, 2022, pp.43, 561~632
26. Ha JW, "Diastolic stress test : invasive and noninvasive testing", JACC Cardiovasc Imaging, 13(1 Pt 2), pp.272~282 (2020)
27. Baumgartner H, "European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE", ASE recommendations for clinical practice, 2009, pp.22, 1~23
28. Shah SJ, "Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction : PROMIS-HFpEF", Eur Heart J, 39, pp.3439~3450 (2018)
29. Taqueti VR, "Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction", Eur Heart J, 39, pp.840~849 (2018)
30. Kim So Ree, "Rationale and Study Design of Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction", International Journal of Heart Failure, 3(4), pp.237~ (2021), 대한심부전학회[DOI]
31. Orde S, "Pearls and pitfalls in comprehensive critical care echocardiography", Crit Care, 21, pp.279~ (2017)
32. Rhodes A, "Surviving sepsis campaign : international guidelines for management of sepsis and septic shock : 2016", Intensive Care Med, 43, pp.304~377 (2017)
33. 이정희, "Clinical significance of changes in the corrected QT interval in stress-induced cardiomyopathy", The Korean Journal of Internal Medicine, 31(3), pp.507~516 (2016), 대한내과학회
34. McLean AS, "Echocardiography in shock management", Crit Care, 20, pp.275~ (2016)
35. Medina de Chazal H, "Stress cardiomyopathy diagnosis and treatment : JACC state-of-the-art review", J Am Coll Cardiol, 72, pp.1955~1971 (2018)
36. Douflé G, "Echocardiography for adult patients supported with extracorporeal membrane oxygenation", Crit Care, 19, pp.326~ (2015)
37. Lee TH, "Impact of left ventricular cavity size on survival in advanced heart failure", Am J Cardiol, 72, pp.672~676 (1993)
38. Park SM, "Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy", Eur J Echocardiogr, 12, pp.887~894 (2011)
39. Rickenbacher PR, "Transplant candidates with severe left ventricular dysfunction managed with medical treatment : characteristics and survival", J Am Coll Cardiol, 27, pp.1192~1197 (1996)
40. Kim MN, "Current status of pharmacologic and nonpharmacologic therapy in heart failure with preserved ejection fraction", Heart Fail Clin, 17, pp.463~482 (2021)
41. Morris DA, "Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction", JACC Cardiovasc Imaging, 11, pp.1405~1415 (2018)
42. Brignole M, "2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology(ESC). Developed in collaboration with the European Heart Rhythm Association(EHRA)", Eur Heart J, 34, pp.2281~2329 (2013)
43. Su MY, "CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF", JACC Cardiovasc Imaging, 7, pp.991~997 (2014)
44. Webb J, "The emerging role of cardiac magnetic resonance imaging in the evaluation of patients with HFpEF", Curr Heart Fail Rep, 15, pp.1~9 (2018)
45. Casolo G, "Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging : diagnostic accuracy of late gadolinium enhancement", Am Heart J, 151, pp.101~108 (2006)
46. Kim RJ, "The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction", N Engl J Med, 343, pp.1445~1453 (2000)
47. Bello D, "Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy", Circulation, 108, pp.1945~1953 (2003)
48. Tarantini G, "Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty", Am J Cardiol, 98, pp.1033~1040 (2006)
49. Baks T, "Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics", J Am Coll Cardiol, 47, pp.40~44 (2006)
50. Ommen SR, "2020 AHA", ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy : executive summary : a report of the American College of Cardiology, Circulation, pp.2020, 142[DOI]
51. Habib G, "Multimodality imaging in restrictive cardiomyopathies:an EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases”of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography", Eur Heart J Cardiovasc Imaging, 18, pp.1090~1121 (2017)
52. Klem I, "Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy", Circulation, 143, pp.1343~1358 (2021)
53. Baggiano A, "Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis", JACC Cardiovasc Imaging, 13(1 Pt 1), pp.69~80 (2020)
54. Fontana M, "Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression", JACC Cardiovasc Imaging, 14, pp.189~199 (2021)
55. Martinez-Naharro A, "Native T1and extracellular volume in transthyretin amyloidosis", JACC Cardiovasc Imaging, 12, pp.810~819 (2019)
56. Terasaki F, "JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version", Circ J, 83, pp.2329~2388 (2019)
57. Ferreira VM, "Cardiovascular magnetic resonance in nonischemic myocardial inflammation : expert recommendations", J Am Coll Cardiol, 72, pp.3158~3176 (2018)
58. Adler Y, "2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)", Eur Heart J, 36, pp.2921~2964 (2015)
59. Knuuti J, "2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes", Eur Heart J, 41, pp.407~477 (2020)
60. le Polain de Waroux JB, "Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction : comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging", Eur Heart J, 29, pp.2544~2551 (2008)
61. Behar JM, "Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapy", Heart Rhythm, 14, pp.1364~1372 (2017)
62. Driessen RS, "Functional stress imaging to predict abnormal coronary fractional flow reserve : the PACIFIC 2 study", Eur Heart J, 43, pp.3118~3128 (2022)
63. Saraste A, "Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets", Eur Heart J Cardiovasc Imaging (2023)[DOI]
64. Allman KC, "Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction : a meta-analysis", J Am Coll Cardiol, 39, pp.1151~1158 (2002)
65. Gertz MA, "Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis(AL) : a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004", Am J Hematol, 79, pp.319~328 (2005)
66. González-López E, "Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction", Eur Heart J, 36, pp.2585~2594 (2015)
67. Witteles RM, "Screening for transthyretin amyloid cardiomyopathy in everyday practice", JACC Heart Fail, 7, pp.709~716 (2019)
68. Ishimaru S, "Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis", Eur Heart J, 26, pp.1538~1543 (2005)

관련 논문AI추천